Business Context and Reporting Period
This Form 8-K filing by Colgate-Palmolive Company covers events occurring on March 10, 2016, and March 14, 2016. The report focuses on corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel and governance disclosures.
Material Changes
- Board Election: On March 14, 2016, the Board elected Dr. C. Martin Harris as a new director. Dr. Harris brings expertise in healthcare and information technology, having served as Chief Information Officer and Chairman of the Information Technology Division of The Cleveland Clinic Foundation since 1996.
- Director Departure: On March 10, 2016, Delano E. Lewis notified the Board of his intention not to stand for reelection at the Annual Meeting of Stockholders on May 6, 2016, to retire at the end of his current term.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. Dr. Harris will receive compensation in accordance with the company's standard director compensation program for non-employee directors.
Key Facts for Investor Verification
- Confirmation of Dr. C. Martin Harris's official start date and committee assignments on the Board.
- Verification of the exact date Delano E. Lewis's term concludes following the May 6, 2016, Annual Meeting.
- Review of the company's proxy statement for details on the director compensation program applicable to Dr. Harris.